The Third Generation Sequencing Market on a global scale was estimated at USD 11.3 billion in 2024 and is forecasted to attain USD 40.7 billion by 2034, with a projected CAGR of 13.8% between 2025 and 2034.
Third Generation Sequencing encompasses a type of dna sequencing method currently being researched. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Market momentum is bolstered by rising need advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Third Generation Sequencing Market Snapshot
Chapter 4. Global Third Generation Sequencing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Technology Estimates & Trend Analysis
5.1. By Technology & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Technology:
5.2.1. Single-Molecule Real-Time (SMRT) Sequencing
5.2.2. Nanopore Sequencing
5.2.3. Others
Chapter 6. Market Segmentation 2: By Product Estimates & Trend Analysis
6.1. By Product & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product:
6.2.1. Instruments
6.2.2. Reagents and Consumables
6.2.3. Services
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
7.2.1. Genome Sequencing
7.2.2. Epigenetics
7.2.3. Transcriptomics
7.2.4. Metagenomics
7.2.5. Others
Chapter 8. Market Segmentation 4: By End-User Estimates & Trend Analysis
8.1. By End-User & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-User:
8.2.1. Academic and Research Institutes
8.2.2. Pharmaceutical and Biotechnology Companies
8.2.3. Hospitals and Clinics
8.2.4. Contract Research Organizations (CROs)
8.2.5. Others
Chapter 9. Third Generation Sequencing Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.1.2. North America Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
9.1.3. North America Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.1.4. North America Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
9.1.5. North America Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe Third Generation Sequencing Market revenue (US$ Million) by By Technology, 2021-2034
9.2.2. Europe Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
9.2.3. Europe Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.2.4. Europe Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
9.2.5. Europe Third Generation Sequencing Market revenue (US$ Million) by country, 2021-2034
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific Third Generation Sequencing Market revenue (US$ Million) by By Technology, 2021-2034
9.3.2. Asia Pacific Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
9.3.3. Asia Pacific Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.3.4. Asia Pacific Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
9.3.5. Asia Pacific Third Generation Sequencing Market revenue (US$ Million) by country, 2021-2034
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America Third Generation Sequencing Market revenue (US$ Million) by By Technology, 2021-2034
9.4.2. Latin America Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
9.4.3. Latin America Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.4.4. Latin America Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
9.4.5. Latin America Third Generation Sequencing Market revenue (US$ Million) by country, (US$ Million) 2021-2034
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. Middle East & Africa
9.5.1. Middle East & Africa Third Generation Sequencing Market revenue (US$ Million) by By Technology, 2021-2034
9.5.2. Middle East & Africa Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
9.5.3. Middle East & Africa Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.5.4. Middle East & Africa Third Generation Sequencing Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
9.5.5. Middle East & Africa Third Generation Sequencing Market revenue (US$ Million) by country, (US$ Million) 2021-2034
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Genomics, Inc.,
10.2.2. GenapSys Inc.,
10.2.3. GATC Biotech AG,
10.2.4. Stratos Genomics, Inc.,
10.2.5. Genia Technologies, Inc.,
10.2.6. Nabsys, Inc.,
10.2.7. Loop Genomics,
10.2.8. Agilent Technologies, Inc.,
10.2.9. QIAGEN N.V.,
10.2.10. Illumina, Inc.,
10.2.11. F. Hoffmann-La Roche AG,
10.2.12. BGI Genomics Co., Ltd.,
10.2.13. Oxford Nanopore Technologies, Ltd.,
10.2.14. Thermo Fisher Scientific Inc.,
10.2.15. Pacific Biosciences of California, Inc